BMI levels are often used in Europe Most guidelines suggest that adults may be considered for these medicines if they have: A BMI of 30 or higher A BMI of 27 or higher, plus a weight-related health issue, such as high blood pressure or raised blood sugar These numbers are a guide
To support the respiratory system
CrossRef Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies Mandeep Kaur, Sakshi Misra, Priyanka Swarnkar, Preeti Patel, Balak Das Kurmi, Ghanshyam Das Gupta, Amrita Singh Biochemical Pharmacology.2023
However: Longer-term safety data (5+ years) is still being collected Individual risk factors vary significantly Regular medical monitoring essential for ongoing safety assessment Some individuals develop side effects requiring discontinuation Long-term cardiovascular benefits observed in some trials (SELECT trial with semaglutide) Healthcare providers should regularly reassess whether continued treatment remains appropriate for individual circumstances based on ongoing benefits, risks, and patient preferences
